Lakefront Biotherapeutics | GLPG - أصول متداولة





أصول متداولة تغيير تاريخ
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Biogen USD 7.31B 1.88B 2026-06
Genmab DKK 2.8B 228M 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
GRIFOLS EUR 5.31B 51M 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Incyte USD 6.03B 542.31M 2026-06
Merck EUR 13.77B 393M 2026-06
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Novartis USD 27.35B 744M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
UCB EUR 6.05B 733M 2025-12
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06